← Back
Eli Lilly
LLY · listed on the New York Stock Exchange · worth $1.23 trillion
$1,373.70
+6.63% today
Since Nov 11, 2025, no insider has bought Eli Lilly stock. They sold it 161 times, $1.75 billion in all. Eleven members of Congress reported trading Eli Lilly in the last year.
Red dot = an insider sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
889.0M shares
100% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
Since Nov 11, 2025, three insiders sold Eli Lilly stock and none bought. Two of the 161 sales are marked on the filing as planned in advance. The biggest seller was Lilly Endowment.
Planned sales
Form 144 notices filed for Eli Lilly in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
Lilly Endowment filed to sell 305,000 shares on 15 Oct; no sale reported yetNotice on SEC.gov
Lilly Endowment filed to sell 300,000 shares on 7 Oct; no sale reported yetNotice on SEC.gov
President Patrik Jonsson filed to sell 6,500 shares on 17 Aug; no sale reported yet10b5-1 plan adopted 17 Feb 2026 · Notice on SEC.gov
Big investors
People and funds that reported owning 5% or more of Eli Lilly, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company. · updateLilly Endowment9.6%Oct 19
US Congress
Members of Congress who reported trading Eli Lilly in the last year. They have up to 45 days to report, so the newest trades show up late.
MemberTradeAmountWhose accountTradedReported
All reports
Every insider trade and SEC report we hold for Eli Lilly.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Aug 11SoldDonald A. ZakrowskiAug 11 · Traded Aug 10 · SVP, Finance, & CAO · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.2,000 @ $1,185.01$2.37M
Aug 10SoldAnat HakimAug 10 · Traded Aug 7 · EVP, GC & Secretary · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.via a trust or family5,000 @ $1,190.00$5.95M
156 more with Pro →Analysts, earnings and news
Analysts' price target
$1,215.79 average
29 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
4 of 4 quarters above
Q1 '26$8.55 a share+$1.76
Q4 '25$7.54 a share+$0.63
Q3 '25$7.02 a share+$1.13
Q2 '25$6.31 a share+$0.72